MY172311A - Hypoxia inducible factor (hif) activity reporter cell line - Google Patents
Hypoxia inducible factor (hif) activity reporter cell lineInfo
- Publication number
- MY172311A MY172311A MYPI2012003492A MYPI2012003492A MY172311A MY 172311 A MY172311 A MY 172311A MY PI2012003492 A MYPI2012003492 A MY PI2012003492A MY PI2012003492 A MYPI2012003492 A MY PI2012003492A MY 172311 A MY172311 A MY 172311A
- Authority
- MY
- Malaysia
- Prior art keywords
- hif
- cell line
- inducible factor
- hypoxia inducible
- reporter cell
- Prior art date
Links
- 206010021143 Hypoxia Diseases 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 230000007954 hypoxia Effects 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 108700008625 Reporter Genes Proteins 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/505—Erythropoietin [EPO]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7038—Hypoxia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2012003492A MY172311A (en) | 2012-08-02 | 2012-08-02 | Hypoxia inducible factor (hif) activity reporter cell line |
| EP13713255.1A EP2880177B1 (en) | 2012-08-02 | 2013-01-29 | Hypoxia inducible factor (hif) activity reporter cell line |
| PCT/MY2013/000013 WO2014021705A1 (en) | 2012-08-02 | 2013-01-29 | Hypoxia inducible factor (hif) activity reporter cell line |
| US14/415,064 US9995730B2 (en) | 2012-08-02 | 2013-01-29 | Hypoxia Inducible Factor (HIF) Activity Reporter Cell Line |
| IN205DEN2015 IN2015DN00205A (https=) | 2012-08-02 | 2013-01-29 | |
| CN201380040870.5A CN104662164A (zh) | 2012-08-02 | 2013-01-29 | 缺氧诱导因子(hif)活性报告细胞系 |
| JP2015525393A JP6309520B2 (ja) | 2012-08-02 | 2013-01-29 | 低酸素誘導因子（ｈｉｆ）活性レポーター細胞株 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2012003492A MY172311A (en) | 2012-08-02 | 2012-08-02 | Hypoxia inducible factor (hif) activity reporter cell line |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY172311A true MY172311A (en) | 2019-11-21 |
Family
ID=48040394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012003492A MY172311A (en) | 2012-08-02 | 2012-08-02 | Hypoxia inducible factor (hif) activity reporter cell line |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9995730B2 (https=) |
| EP (1) | EP2880177B1 (https=) |
| JP (1) | JP6309520B2 (https=) |
| CN (1) | CN104662164A (https=) |
| IN (1) | IN2015DN00205A (https=) |
| MY (1) | MY172311A (https=) |
| WO (1) | WO2014021705A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101849964B1 (ko) * | 2016-07-26 | 2018-04-19 | 울산대학교 산학협력단 | Il-7 발현 리포터 세포주 및 이를 이용한 면역결핍 질환 치료제 스크리닝 방법 |
| AU2021240417A1 (en) * | 2020-03-26 | 2022-10-20 | AskBio Inc. | Forskolin-inducible promoters and hypoxia-inducible promoters |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834306A (en) * | 1994-12-23 | 1998-11-10 | Sri International | Tissue specific hypoxia regulated therapeutic constructs |
| WO2005001136A1 (en) * | 2003-06-04 | 2005-01-06 | Irm Llc | Methods and compositions for modulating erythropoietin expression |
-
2012
- 2012-08-02 MY MYPI2012003492A patent/MY172311A/en unknown
-
2013
- 2013-01-29 JP JP2015525393A patent/JP6309520B2/ja not_active Expired - Fee Related
- 2013-01-29 US US14/415,064 patent/US9995730B2/en not_active Expired - Fee Related
- 2013-01-29 CN CN201380040870.5A patent/CN104662164A/zh active Pending
- 2013-01-29 IN IN205DEN2015 patent/IN2015DN00205A/en unknown
- 2013-01-29 EP EP13713255.1A patent/EP2880177B1/en not_active Not-in-force
- 2013-01-29 WO PCT/MY2013/000013 patent/WO2014021705A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20150168376A1 (en) | 2015-06-18 |
| EP2880177B1 (en) | 2017-07-19 |
| JP6309520B2 (ja) | 2018-04-11 |
| IN2015DN00205A (https=) | 2015-06-12 |
| CN104662164A (zh) | 2015-05-27 |
| WO2014021705A1 (en) | 2014-02-06 |
| JP2015524272A (ja) | 2015-08-24 |
| EP2880177A1 (en) | 2015-06-10 |
| US9995730B2 (en) | 2018-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX337984B (es) | Variantes de alfa amilasa y polinucleotidos que codifican la misma. | |
| MX2014002415A (es) | Variantes de glucoamilasas y polinucleotidos que las codifican. | |
| MX355356B (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| MX354704B (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| MX2014004292A (es) | Variantes de glucoamilasas y polinucleotidos que las codifican. | |
| MX353621B (es) | Variantes de alfa-amilasa. | |
| MX2012007709A (es) | Variantes de alfa-amilasa con estabilidad mejorada. | |
| MX2013007853A (es) | Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| IN2014CN00597A (https=) | ||
| MX2015000312A (es) | Polipeptidos que tienen actividad lipasa y polinucleotidos que los codifican. | |
| MX337919B (es) | Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| MX351916B (es) | Polipeptidos que tienen actividad de lisozima y polinucleotdos que los codifican. | |
| EP4428141A3 (en) | Rna-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | |
| IL240881A0 (en) | Expression of the t cell balance gene, preparations, materials and methods for its use | |
| EP4442808A3 (en) | Taurine supplemented cell culture medium and methods of use | |
| MX2013007720A (es) | Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican para los mismos. | |
| IN2015KN00265A (https=) | ||
| MX2012011774A (es) | Polipeptidos que tienen actividad de glucoamilasa y polinucleotidos que codifican los mismos. | |
| MX2021013104A (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
| MX2013004892A (es) | Polipeptidos que tienen actividad de fosfolipasa c y polinucleotidos que codifican los mismos. | |
| MX2014001594A (es) | Polipeptidos que tienen actividad de celulasa y polinucleotidos que los codifican. | |
| NZ729980A (en) | Genes involved in noscapine production | |
| SG10201805087VA (en) | Artificial match-type mirna for controlling gene expression and use therefor | |
| WO2014195356A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
| MX349517B (es) | Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos. |